申请人:ABBVIE INC
公开号:WO2014089904A1
公开(公告)日:2014-06-19
The invention provides a compound of Formula (I), pharmaceutically acceptable salts, pro-drugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variable are defined herein. The compounds of the invention are useful for treating immunological and oncological conditions.